key: cord-0285114-018tae9n authors: Tang, M. Y.; Graham, F. E.; O'Donnell, A.; Beyer, F.; Richmond, C.; Sniehotta, F. F.; Kaner, E. F. S. title: Effectiveness of shared medical appointments delivered in primary care for improving health outcomes in patients with long-term conditions: a systematic review of randomised controlled trials date: 2022-03-24 journal: nan DOI: 10.1101/2022.03.24.22272866 sha: c6e22a718b6346a0987f8bcb4e0b4701de8cb21b doc_id: 285114 cord_uid: 018tae9n Background: Shared medical appointments (SMAs) have the potential to address interlinked challenges of limited capacity in primary healthcare and rising prevalence of patients with multiple long-term conditions (LTCs). This review aimed to examine the effectiveness of SMAs compared to one-to-one appointments in primary care at improving health outcomes and reducing demand on healthcare services. Methods: We searched for randomised controlled trials (RCTs) of SMAs involving patients with LTCs in primary care across six databases from 2013 and added eligible papers identified from previous relevant reviews. Data were extracted and outcomes narratively synthesised, meta-analysis was undertaken where possible. Results: Twenty-three unique trials were included. SMA models varied in terms of components, mode of delivery and target population. Most trials recruited patients with a single LTC, mostly commonly diabetes (n=13), although eight trials selected patients with multiple LTCs. There was substantial heterogeneity in outcome measures which we categorised into health outcomes (biomedical indicators, psychological and well-being measures), behavioural outcomes, and resource use. Meta-analysis showed that participants in SMA groups had lower diastolic blood pressure than those in usual care (d=-0.123, 95%CI = -0.22, -0.03, k=8). No statistically significant differences were found across other outcomes. Where individual studies showed significant differences (patient self-efficacy), these trended in favour of SMAs. Compared with usual care, SMAs had no significant effect on healthcare service use. Conclusions: SMAs were at least as effective as usual care in terms of health outcomes and did not lead to increased healthcare service use in the short-term. They show some potential in improving self-efficacy which may boost self-care. To strengthen the evidence base, future studies should target standardised behavioural and health outcomes and clearly report SMA components so key behavioural ingredients can be identified. Similarly, transparent approaches to measuring costs would improve comparability between studies. Shared Medical Appointments (SMAs), also known as group consultations, are a model of care with the potential to address the interlinked challenges of limited capacity in primary care and rising prevalence of patients with multiple long-term conditions (LTCs) [1, 2] . SMAs are longer appointments (typically 60-120 minutes) whereby patients with the same LTCs meet with their physician together [3] . SMAs are typically co-led and/or facilitated by healthcare professionals, such as nurses, pharmacists, psychologists, and physiotherapists. The group typically consists of between 6-10 patients and may include family members and caregivers [4] . There are various models of SMA but generally they retain some features of a standard one-to-one appointment such as physical examinations and personalised review of medical charts [2] . In addition, SMAs provide participants an opportunity to ask questions of clinicians and other patient and receive formal education and counselling during the group session. SMAs have been used to deliver care for a range of health conditions including diabetes, hypertension, and chronic pain; though there is potential for wider application, including multimorbidity [5] . A recent synthesis of qualitative literature found that most patients and primary care practitioners regarded SMAs positively [6] . Key benefits included improved patient selfconfidence and motivation for self-management; whilst practitioners felt that SMAs had the potential to provide a more efficient and effective way of delivering care [6] . Previous reviews of effectiveness were inconclusive but evidence, largely from the United States (US) and Australia, reported a promising effect of group consultations for some biomedical measures. For example, improvements in glycated haemoglobin A1C (HbA1C) and systolic blood pressure (SBP) were greater in patients attending SMAs compared to usual care for diabetes [4, 7] . However, previous reviews include studies that evaluate the use of SMAs as follow-up appointments after secondary care treatment [4] . It is unclear whether these types of group appointments are effective in supporting improved ongoing management of LTCs in primary care. Responding to these evidence gaps, we aimed to examine the effects of SMAs delivered in primary care on health outcomes and healthcare service use in patients with LTCs. We sought to answer two overarching research questions: Are SMAs effective in improving health outcomes for patients with one or more long-term conditions? . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022 Do SMAs reduce healthcare service use by patients with one or more longterm conditions? This systematic review follows Cochrane Handbook Guidance [8] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [9] . This study was registered on PROSPERO (CRD42020173084). Regarding protocol changes, we proposed coding of Behaviour Change Techniques Taxonomy V1 (BCTTv1) [10] used in SMAs and associated with changes in outcomes. However, most included studies did not report the required detail and so instead we narratively described this information. Studies were included if they met the criteria outlined in Table 1 . Adult patients (>18 years of age) with one or more long-term conditions who have attended at least one shared medical appointment (SMA) in a primary care setting were eligible for inclusion. Patients in primary care settings who were seen by a secondary care specialist during the SMA were excluded. All countries were eligible for inclusion. SMAs/group consultations/group visits conducted in primary care setting, delivered by a primary care healthcare professional (e.g. nurse, doctor, pharmacist), were eligible for inclusion. The present review considered SMAs to be clinical encounters in which groups of patients with the same/similar long-term condition meet with a healthcare professional for routine care. The SMA must have included one-to-one time for every patient in attendance. Therefore, peer support groups were excluded. Comparison/control No restrictions -usual care, active control (e.g., another SMA model). Behavioural outcomes -e.g., healthcare utilisation, physical activity, medication adherence. Disease-specific measures -e.g., Haemoglobin A1C (HbA1C). Biophysical health indicators -e.g., cholesterol, weight, BMI. Cost/resource use. Only randomised controlled trials that were published in peer-reviewed journals were eligible for inclusion. backward citation searches of the included trials, including those in relevant systematic reviews [4, 5, 11, 12] , were also included in the review. Screening and data extraction was facilitated using the systematic review management tool, Covidence [13] . Two reviewers independently screened all titles and abstracts against the inclusion criteria, and a third reviewer adjudicated any disagreements. This process was also applied to the screening of full-text papers. Information relating to the study design, population, intervention, form of delivery[14] (e.g. experience/training of the providers and facilitators), outcomes, and results were extracted from all relevant papers using a data extraction form (see S2). All information was doubleextracted by two researchers, with disagreements resolved through discussion or third-party moderation. Where data were reported for several time-points, the data-point closest to the end of the SMA intervention was used to calculate the effect size as this would be when the largest effects attributable to the SMA is expected. If available, intention-to-treat data were used to calculate effect sizes. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 24, 2022. ; Two researchers independently assessed the quality of all included studies using the Cochrane Risk of Bias Tool [15] . Percentages of judgements (high, low, or unclear) for each domain was calculated across the studies. We mapped all reported outcomes into the following categories agreed by the wider research team to best reflect SMA effectiveness and efficiency: biomedical health indicators, psychological and well-being measures, behavioural outcomes, and cost and resource. Meta-analyses were performed in StataIC 15. Given the heterogeneity between studies, a random-effects model was used [16] . Meta-analyses were conducted where there were at least two studies reporting a specific outcome [17] . Outcome effect sizes were calculated as Cohen's D (standardised mean difference). Heterogeneity was assessed using Higgins I-Square (I 2 ), whereby 50-90% was considered as representing substantial heterogeneity [18] . Authors were contacted for additional information if data needed to calculate effect sizes were not sufficiently reported in the published paper(s). Where this information could not be obtained from authors, p-values and confidence intervals were used to calculate effect sizes [8] . Only studies in which the comparator was usual care were pooled into the metaanalysis. Using meta-regression, sensitivity analyses were conducted to explore whether results differed according to sources of bias identified from the risk of bias assessment and the omission of outliers. Studies that were too heterogeneous to perform meta-analysis (where the comparator was not usual care) were synthesised narratively. For each outcome measure, evidence of an effect was determined by the p-values reported in the papers. To assess the certainty of the evidence, number of study participants, confidence intervals and the consistency of effects across studies, the risk of bias of the studies, how directly the included studies address the planned question (directness) were taken into consideration. Characteristics of the included studies . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Twenty-three unique trials (reported in thirty-four papers) were identified, for PRISMA details see Figure 1 and Table 2 . See S3 for list of included papers. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Multiple papers for the same trial were found therefore we bolded the one used as the index paper throughout the rest of the paper. ^Chronic conditions (including asthma, COPD, heart failure, diabetes, arthritis, deafness, blindness), *Age in years mean (standard deviation), **enhanced usual care-patients required to attend 2 diabetes group education sessions. CRRC-Cardiovascular Risk Reduction Clinic, IWM-intensive weight management, SM-Self-management, SMA-Shared medical appointment, UC-usual care. . It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Sixteen trials (70%) were for a single LTC, of these: 13 were for diabetes [23, 25, 26, [29] [30] [31] [32] [33] [34] [37] [38] [39] 53] , two for hypertension [50, 51] ; and one was for osteoporosis [52] . Eight trials considered multiple LTCs: three were diabetes and hypertension/cardiovascular risk [40] [41] [42] 46] ; one was diabetes and depression [43] , one was for overweight patients with diabetes [44] ; one was chronic pain and depression [22] : and one included multiple LTCs including: arthritis, hypertension, cancer, deafness and diabetes [19] . Overall, 20/23 (87%) of trials focused on patients with diabetes. Nineteen trials (83%) were conducted in the US [19, 22, 23, 25, 26, 29, 30, 33, 34, [37] [38] [39] [40] [41] [42] [43] [44] 46, 53] , two in China [32, 50] and one each in Australia [31] , Germany [51] and the United Kingdom [52] . Twelve trials were measured the effectiveness, impact or efficacy of SMAs compared to usual care [19, 22, 23, 26, 29, 32, 33, 38, 39, 42, 46, 53] , nine trials examined feasibility parameters [24, 30, 31, 34, 37, 38, 43, 50] , and two trials were non-inferiority/superiority trials [44, 45, 52] . In eight trials (35%) participants were veterans or military personnel [29, 33, [40] [41] [42] [43] [44] 46] . Participants were from low-income communities in four trials [22, 23, 37, 38] , and uninsured communities in three US trials [25, 26, 34] . Three trials were tailored for non-English speaking participants, where written materials were available in Spanish [34, 38, 53] . The majority of participants were over 50 years old, the mean age of participants ranged between 50.5 [21, 22] to 74 years old [52] . Two trials were specifically for older patients over 55 or 60 years respectively [19, 51] , and two trials excluded patients over 75 [44] and 80 years [32] . Twelve trials (52%) had a majority of female participants [19, 23, 24, 32, 37, 38, 50, 52] . Ten trials had majority of male participants [29] [30] [31] 33, [40] [41] [42] [43] [44] 46] . Two trials did not report the gender balance of participants [51, 53] . Five studies had a majority White population [22, 29, 39, 42, 43] , six trials had a majority Black population [23, 25, 26, 30, 44, 46] , three trials had a majority Hispanic population [37, 38, 53] , two trials had a majority Asian population [31, 32] , and one trial had a majority White-Latino population [34] . Five studies did not report the ethnicity of participants [19, 40, [50] [51] [52] . Most trials (n=18, 78%) had a two-arm design that compared SMAs with usual care, typically a one-to-one (1:1) appointment with primary care physician [19, 22, 23, 25, 26, 31, 32, [37] [38] [39] [40] [41] [42] [43] 46, 50, 52, 53] . In three other two-arm trials, the comparator was a 1:1 appointment plus two diabetes group education sessions [33] , an SMA without an integrated weight management programme [44] or an SMA with a personal health planning component (PHP) [30] . Two trials had a delayed six-month waitlist control design [37, 38] . Two trials had a three-arm design; one examined the effectiveness of a cardiovascular risk reduction clinic . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; https://doi.org/10.1101/2022.03.24.22272866 doi: medRxiv preprint compared with group medical visits and usual care [41] , a second compared an automated telephone self-management service with SMAs and usual care [34] . Trial outcome measures varied across trials though most included behavioural measures, biomedical health indicators and psychological and well-being measures. Full details of all outcome measures reported by the studies are presented in S4. Risk of bias item across the studies was generally low across the items, except for 'Blinding of participants and personnel' (83% of trials) (See S5). There were no differences for any of the outcomes according to the risk of bias assessment criteria relating to random sequence generation, allocation concealment, blinding, incomplete outcome data, and selected reporting (see S5). Of the 16 trials measuring HbA1c (%), nine trials [23, 26, 31, 34, 38, [41] [42] [43] which compared SMA to usual care were included in a meta-analysis. No statistically significant difference between SMAs and usual care was found for HbA1c (%) at follow-up (d=-0.098, 95%CI = -0.34, 0.14, k=9) (p=0.420) (see Figure 2a ). Substantial heterogeneity was observed (I 2 = 70.9%). Of five other SMA trials reporting HbA1c (%) but not in the metaanalysis [25, 39, 40, 46] , only one reported significant group differences, whereby the SMA group had significantly higher odds of attaining HbA1c goals (< 7%) compared to usual care [23] . However, this was a high risk of bias study, scoring 'unclear' across the six domains. However, this was a high risk of bias study, scoring 'unclear' across the six domains. The pooled effect remained similar when Ee et al. (2020) [31] was removed as an outlier in the sensitivity analysis due to wide 95%CIs, (d=-0.120, 95%CI = -0. 37 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; https://doi.org/10.1101/2022.03.24.22272866 doi: medRxiv preprint 0.22, -0.03, k=8) (p=0.008), whereby participants in the SMA group had lower DBP than those in usual care (see Figure 2b ). The pooled effect remained similar (d=-0.194, 95%CI = -0.35, -0.04, k=7) (p=0.016) when Gao et al. (2015) [50] , the study with the largest sample size (1204), was omitted in the sensitivity analysis. Of the three studies not included in the meta-analysis [26, 32, 46] , one trial of SMAs for diabetes and hypertension reported that mean DBP was lower in the SMA group (78.3 mmHg) than in the usual care group (82.1 mmHg) at 12 months [46] . Of 13 trials reporting SBP [23, 26, 29, 31, 32, 34, 37, 38, [40] [41] [42] 46, 50] , nine could be metaanalysed [23, 29, 31, 34, 37, 38, 41, 42, 50] . No statistically significant difference between SMAs and usual care was found for SBP at follow-up (d=-0.018, 95%CI = -0.11, 0.08, k=9) (p=0.709), with lows level of heterogeneity observed (I 2 = 3.8%) (see Figure 2c ). Of the four trials not in the meta-analysis [26, 32, 40, 46] , two moderately robust studies reported statistically significant group differences in SBP at follow-up [32, 46] , whereby the SMA group showed greater decreases in SBP compared to usual care. No statistically significant effect of SMAs compared to usual care was found for other biomedical health outcomes including: total cholesterol, high density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, weight, and BMI (see S6). Three trials had enhanced SMAs as their comparator [30, 33, 44] (2020) reported patient weight loss in the SMAs with intensive weight management was comparable to weight loss amongst patients attending SMAs but statistical significance was unclear [44] . It is possible that other studies could not detect statistically significant differences between arms due to small sample sizes. Psychological and well-being measures . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022 . ; Six trials reported quality of life (QoL) outcomes [19, 22, 31, 34, 40, 42] of which two trials reported significant group differences [19, 34] . One trial of SMAs for chronically ill patients with multiple LTCs found that participants in the SMA group (M=7.2, SD=1.8) reported significantly better QoL than the usual care group (M=6.3, SD=2.0) (p=.002) at 24 months [19] . Schillinger et al., (2008) measured QoL using the short form (SF)-12 instrument which comprised of mental health and physical health subscales. Improvements in SF-12 mental health was observed for SMA group compared to SMA (effect size=0. 31, p=0.03) and usual care (effect size=0.18, p=0.2) [34] . However, this was considered as a high risk of bias study, with high/unclear judgements across four out of six domains. Four trials measured patient satisfaction [19, 30, 39, 52] . Scott et al. (2004) reported significant differences at follow-up with SMA patients reporting higher satisfaction with practitioner discussions compared to controls [19] . The other three studies found no differences. Self-efficacy was measured in nine trials [19, 22, 23, 32, 34, 40, 43, 46, 50] , of which five studies were included in meta-analysis [19, 22, 23, 34, 50] . No statistically significant effect was found (d=0.167, 95%CI = -0.08, 0.41, k=5) (p=0.182) (See S7). High levels of heterogeneity were observed (I 2 =78.9%). Of the four other studies not included in meta-analysis [32, 40, 43, 46] , two reported that SMA patients had significant improvements in self-efficacy to manage diabetes compared to usual care [32, 46] . No statistically significant effect of SMAs compared to usual care was found for other depression (see S7). Drake et al. (2018) reported significant improvements in self-efficacy, as measured using the Diabetes Empowerment Scale, for the PHP SMA group compared to the standard SMA group [30] . Naik et al. (2011) did not find any differences in diabetes self-efficacy scores between the SMA group and the traditional diabetes group education group [33] . Hospital admissions . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; Seven trials reported hospital admissions within six to 24 months [19, 23, 25, 39, 41, 43, 46] and three were included in a meta-analysis [19, 23, 41] . There was no difference between SMAs and usual care in terms of hospital admissions at follow-up (d=-0.016, 95%CI = -0.38, 0.35, k=3; (p=0.931) (see Figure 3a ). Substantial heterogeneity was observed (I 2 = 71.1%). None of the other four trials [25, 39, 43, 46] reported significant group differences for hospital admissions at follow-up. Of eight relevant trials [19, 22, 23, 25, 39, 41, 43, 46] , four were included in a metaanalysis [19, 23, 39, 41] . No difference between SMAs and usual care was found for admissions to emergency departments at follow-up (d=-0.083, 95%CI = -0.30, 0.13, k=4, p=0.453 (Figure 3b ). Considerable heterogeneity was observed (I 2 = 61.7%). Of four trials not in the meta-analysis [22, 25, 43, 46] , only Edelman et al. (2010) reported significant group differences in emergency department use favouring SMAs with 0.4 (95%CI = 0.20, 0.70) fewer emergency care visits than the usual care group over the 12-month study period [46] . Four trials reported the number of primary care visits participants made during the study period [19, 39, 43, 46] . Three were pooled in a meta-analysis [19, 39, 43] showing no statistically significant difference (d=0.034, 95%CI = -0.09, 0.16, k=3, p=0.575) (see Figure 3c ). Edelman et al. (2010) , which could not be included into the meta-analysis, reported that SMA participants had significantly fewer primary care visits than controls (5.3 vs. 6.2 per patient-year) at 12 months [46] . No statistically significant effect of SMAs compared to usual care were found for other behavioural outcomes including medication adherence and physical activity (see S8) Few studies reported the costs involved in the delivery of the SMA and those that did were unclear about cost parameters (i.e whether scheduling and preparation time was included or not) or how the costs were attributed. One trial of diabetes SMAs reported that overall costs . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; https://doi.org/10.1101/2022.03.24.22272866 doi: medRxiv preprint per patient were higher in SMAs than those in usual care group for the study period of six months [25] . However, another trial found no significant difference between SMA and usual care in terms of total costs incurred during the 24 months study period, but showed a positive effect of the SMA at 13 months post-study where cost decreased by 6% for the SMA but increased by 13% for usual care p<0.01 [39] . The SMA trial for osteoporosis reported that the costs incurred during the study period were lower for the SMA group compared to control groups [52] . A trial of chronic condition SMAs (reported that total costs incurred by the SMA group were lower than the usual care group [19] . There was much variation in the SMAs models reported by studies (see S9 for detailed description). Key features of SMA models were: the opportunity for each patient to have individual 1:1 time with a clinician (23 trials), facilitated group discussion or group question and answer session (15 trials) [19, 22, 25, 26, 29, 30, [32] [33] [34] [37] [38] [39] 40, 43, 46, 50] , 'group education' (14 trials) [19, 23, 25, [31] [32] [33] 37, 38, 41, 42, 43, 44, 46, 50] , and the opportunity to socialise (11 trials) [19, 22, 25, 26, 29, 32, 34, 37, 38, 46, 50] . SMAs were delivered face-to-face in all trials, although three SMA models included digital technologies, namely website and telephone support [22] and phone calls or text message support and/or reminders [37, 38] . In three trials [33, 41, 52] SMAs were delivered by a single healthcare professional though mostly they were delivered by multidisciplinary teams. Professionals most commonly involved were family physicians [19, 23, 24, [30] [31] [32] [33] [34] 39, 44, 46, 50, 51, 53] , nurse practitioners [23, [26] [27] [28] [29] 32, 44, 45] or nurses [19, 20, 39, 40, 42, [46] [47] [48] [49] [50] 53 ]. It was not always possible to tell what role each member of staff had in the delivery of the SMA. Provider characteristics other than profession or role were rarely reported, though two trials involving a majority Hispanic/Latino participants reported that the community health worker and or physician were bilingual [34, 38] . Four trials reported that the same interventionists attended all visits for a particular group [40, 44, 46, 51] . One trial of diabetes SMAs reported that group assignments were maintained for all SMAs to facilitate peer interactions and relationships within groups [33] . The consistency in group composition in terms of patient and interventionists attending each session was not reported by most studies. Our systematic review identified 23 unique RCTs comparing SMAs for one or more LTCs to usual care or an enhanced SMA. We found that SMAs significantly improved diastolic blood pressure for diabetes patients and there were non-significant trends favouring SMAs for . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; QoL, patient satisfaction and patient self-efficacy. Improved self-efficacy may help boost self-care. In line with the findings of previous reviews [12] , no harm was observed for the use of SMAs across these outcomes and there was no effect on healthcare service use compared to usual care. This indicates that whilst SMAs may not be superior to usual care in terms of most health outcomes or reducing demand on services, they do not appear to increase demand at least in the short-term. Evidence reporting costs is too heterogeneous to draw firm conclusions. Like previous reviews of SMAs for LTCs [4, 12, 54] , more than half of the included RCTs included patients with diabetes, and as such the most commonly reported outcome measure was HbA1C. However, unlike previous reviews [7, 55] , we did not observe any significant improvements in HbA1c. This may be because previous reviews included trials in secondary care. Our meta-analysis showed that SMA participants had lower DBP compared to patients who received usual care. This effect remained even when a large study [50] with 1204 participants was omitted in the sensitivity analyses. Whilst significant differences were not found for the other biomedical outcomes between the SMA and usual care groups, individual trials reporting a significant difference suggest trends favouring SMA for outcomes including SBP and cholesterol. [4] reported a mixed pattern of changes. Our meta-analyses show that SMAs do not differ from usual care in terms of healthcare utilisation. There is no evidence in the present data to suggest that patients compensate for a lack of privacy by returning to primary care again or that they risk hospitalisation because issues are not adequately addressed during the SMA session(s). However, it should be noted that the key source of bias across the included studies was the lack of blinding of participants and personnel. Therefore, possible selection bias may result in recruitment of SMA participants with less concern about sharing their personal/medical information. In comparison to biomedical outcomes and psychological outcomes, behavioural outcomes were less frequently reported by studies. This echoes the findings of Edelman et al. (2015) [46] which found there to be limited data on key patient-centred outcomes such as patient satisfaction. Behavioural outcomes such as medication adherence are important across many LTCs and are key to understanding how patients are self-managing their . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 24, 2022. ; conditions. In line with Kelly et al.'s (2017) [12] recommendation, future studies should report outcome effectiveness measures that are common or comparable across different LTCs such as physical activity, self-efficacy, medication adherence, and quality of life. It would be advantageous to agree a Core Outcome Set (COS), consisting of a standardised group of outcomes, to be reported by all SMA trials. This can help with future evaluations of SMAs through reducing heterogeneity and facilitating meta-analysis and ensuring that outcome measures are relevant to key stakeholders [56] . Although previous reviews have explored the effectiveness of SMAs in improving health outcomes, this review provides a focus on primary care which is key to managing LTCs. We found ten additional trials with 1160 participants since the comprehensive work by Booth et al. (2015) [4] indicating a rapidly growing field. We used robust methods whereby our search strategy was developed with input from Information Specialists through an iterative process and key stages of the review (including screening, data extraction, and quality appraisal) were undertaken independently by two reviewers. We included studies regardless of type of LTC so that we were able to summarise all the available evidence on effectiveness of SMAs for LTCs in primary care in one analysis. However, evidence of an effect was determined by p=<.0.5 in the papers. This assumes that studies were adequately powered, which may not be the case, particularly for some of the secondary outcomes of the included studies. Our narrative synthesis is limited by what is reported thus important contextual factors may be missing from authors' descriptions of the SMAs. Similar components may be described differently by different authors or, conversely, similar descriptions are used to describe different components. Standardised taxonomies for describing mode of delivery and intervention content would help to identify important behavioural components and key implementation processes that contribute to intervention effectiveness. However, for this to be possible, it is also important that interventionists clearly specify which target behaviours (e.g. to increase physical activity) the SMAs aim to change and also measure fidelity to ensure that the session(s) are delivered as intended to achieve optimum effects [57] . Further, theoretical underpinnings were lacking in the included SMA interventions, making it difficult to identify 'mechanisms of action' through which interventions bring about change [58] . Future SMAs interventions should be theory-based and be explicit in reporting its theoretical underpinnings. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 24, 2022. ; Where multiple healthcare professionals are involved in the SMA, their key role and purpose in the SMA were rarely clearly defined. There was also limited reporting on the composition of the SMA groups across some of the included studies (i.e. how patients were selected for recruitment and size). Therefore, it is unclear which groups of patients might benefit from attending the same SMAs together and what implications SMAs may have for interventiongenerated health inequalities. One third of the included studies were conducted on US veterans and one third of studies have involved participants from low-income/uninsured population groups. Generalisability of these groups to other healthcare settings in other countries is unclear. Further investigations into SMAs for patients with one or more LTCs is required, including a wider variety of LTCs (such as asthma and chronic obstructive pulmonary disease) and with more diverse population groups. For example, including lowincome and disadvantaged groups in other countries, including the UK. This review is the first to examine the effects of SMAs delivered in primary care on health outcomes and healthcare service use in patients with one or more LTCs. Our review suggests that SMAs are unlikely to result in less favourable outcomes to patients with LTCs compared to usual care. To identify key intervention components that contribute to effectiveness, future studies will benefit from using standardised taxonomies to report intervention content. The use of an evaluation framework, with a core outcome set, is recommended to improve evidence in this field. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 24, 2022. ; CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 24, 2022. ; Making time in general practice: freeing GP capacity by reducing bureaucracy and avoidable consultations, managing the interface with hospitals and exploring new ways of working Shared medical appointments Process and Systems: A systems approach to embedding group consultations in the NHS What is the evidence for the effectiveness, appropriateness and feasibility of group clinics for patients with chronic conditions? A systematic review Shared medical appointments and patient-centered experience: A mixed-methods systematic review Barriers and facilitators to implementation of shared medical appointments in primary care for the management of long-term conditions: a systematic review and synthesis of qualitative studies Shared Medical Appointments for Patients with Diabetes Mellitus: A Systematic Review Cochrane Handbook for Systematic Reviews of Interventions version 6 The PRISMA 2020 statement: An updated guideline for reporting systematic reviews The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions Cochrane Handbook for Systematic Reviews of Interventions Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: A 2-year randomized trial of the Cooperative Health Care Clinic Reducing emergency visits in older adults with chronic illness. A randomized, controlled trial of group visits Design of the integrative medical group visits randomized control trial for underserved patients with chronic pain and depression Effectiveness of integrative medicine group visits in chronic pain and depressive symptoms: A randomized controlled trial Imbedding Interdisciplinary Diabetes Group Visits Into a Community-Based Medical Setting Evaluating group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes Evaluating concordance to American Diabetes Association standards of care for type 2 diabetes through group visits in an uninsured or inadequately insured patient population Group visits: Promoting adherence to diabetes guidelines Further evaluating the acceptability of group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes Do Diabetes Group Visits Lead to Lower Medical Care Charges? Effectiveness of Prediabetes Nutrition Shared Medical Appointments: Prevention of Diabetes Integration of Personalized Health Planning and Shared Medical Appointments for Patients with Type 2 Diabetes Mellitus Shared Medical Appointments and Mindfulness for Type 2 Diabetes-A Mixed-Methods Feasibility Study Effectiveness of using group visit model to support diabetes patient self-management in rural communities of Shanghai: A randomized controlled trial Comparative effectiveness of goal setting in diabetes mellitus group clinics: Randomized clinical trial Seeing in 3-D: Examining the reach of diabetes self-management support strategies in a public health care system Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a 3-arm randomized trial Influence of patient characteristics on assessment of diabetes self-management support Integrating CHWs as Part of the Team Leading Diabetes Group Visits: A Randomized Controlled Feasibility Study A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial Chronic care clinics for diabetes in primary care: A system-wide randomized trial Pharmacist-Led Shared Medical Appointments for Multiple Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: A randomized controlled trial Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial Pharmacist-Led Group Medical Appointments for the Management of Type 2 Diabetes with Comorbid Depression in Older Adults Comparison of Group Medical Visits Combined with Intensive Weight Management vs Group Medical Visits Alone for Glycemia in Patients with Type 2 Diabetes: A Noninferiority Randomized Clinical Trial Jump starting shared medical appointments for diabetes with weight management: Rationale and design of a randomized controlled trial Medical Clinics Versus Usual Care for Patients With Both Diabetes Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention Can group medical clinics improve lipid management in diabetes? Effect of a group medical clinic for veterans with diabetes on body mass index Evaluation of group visits for Chinese hypertensives based on primary health care center Quality improvement in chronic care delivery for patients with arterial hypertension through Group Medical Visits: Patient acceptance and attendance in the German pilot project Osteoporosis group consultations are as effective as usual care: Results from a non-inferiority randomized trial Shared medical appointments in a residency clinic: An exploratory study among hispanics with diabetes Shared Medical Appointments for Chronic Medical Conditions : A Systematic Review. VA Evidence-based Synth Progr Reports Published Online First Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis Core Outcome Sets Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium Behavior Change Techniques and Their Mechanisms of Action: A Synthesis of Links Described in Published Intervention Literature The authors would like to thank the following authors for providing additional data used in this review: Dr Renee E Cole, Dr Connor Drake, Dr William Yancy, and Professor Tracey Taveria. We would also like to thank Professor Dawn Craig for her comments on an earlier draft of this manuscript.